Literature DB >> 19608805

Children with infantile neuronal ceroid lipofuscinosis have an increased risk of hypothermia and bradycardia during anesthesia.

Ning Miao1, Sondra W Levin, Eva H Baker, Rafael C Caruso, Zhongjian Zhang, Andrea Gropman, Deloris Koziol, Robert Wesley, Anil B Mukherjee, Zenaide M N Quezado.   

Abstract

BACKGROUND: Neuronal ceroid lipofuscinoses (NCLs) are a group of autosomal recessive neurodegenerative diseases characterized by lysosomal accumulation of autofluorescent material in neurons and other cell types. The infantile NCL (INCL) subtype is rare (1 in >100,000 births), the most devastating of childhood subtypes, and is caused by mutations in the gene CLN1, which encodes palmitoyl-protein thioesterase-1.
METHODS: To investigate the incidence of hypothermia and bradycardia during general anesthesia in patients with INCL, we conducted a case-control study to examine the perianesthetic course of patients with INCL and of controls receiving anesthesia for diagnostic studies.
RESULTS: Eight children with INCL (mean age 25 mo [range, 10-32] at first anesthetic) and 25 controls (mean age 44 mo [range, 18-92]) underwent 62 anesthetics for nonsurgical procedures. Patients with INCL had neurologic deficits including developmental delay, myoclonus, and visual impairment. Patients with INCL had lower baseline temperature (36.4 +/- 0.1 vs 36.8 +/- 0.1, INCL versus controls, P < 0.007), and during anesthesia, despite active warming techniques, had significantly more hypothermia (18 vs 0 episodes, P < 0.001) and sinus bradycardia (10 vs 1, P < 0.001) compared with controls. INCL diagnosis was significantly associated with temperature decreases during anesthesia (P < 0.001), whereas age, sex, and duration of anesthesia were not (P = NS).
CONCLUSIONS: We report that patients with INCL have lower baseline body temperature and during general anesthesia, despite rewarming interventions, are at increased risk for hypothermia and bradycardia. This suggests a previously unknown INCL phenotype, impaired thermoregulation. Therefore, when anesthetizing these children, careful monitoring and routine use of warming interventions are warranted.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19608805      PMCID: PMC2743022          DOI: 10.1213/ane.0b013e3181aa6e95

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  23 in total

Review 1.  The neuronal ceroid-lipofuscinoses.

Authors:  Matti Haltia
Journal:  J Neuropathol Exp Neurol       Date:  2003-01       Impact factor: 3.685

2.  Anesthesia in a child with Batten disease.

Authors:  Senthil Gopalakrishnan; Saif Sidduiqui; James F Mayhew
Journal:  Paediatr Anaesth       Date:  2004-10       Impact factor: 2.556

3.  Anesthesia for a patient with Kufs' disease.

Authors:  R J Defalque
Journal:  Anesthesiology       Date:  1990-11       Impact factor: 7.892

4.  Anesthetic management for a patient with Jansky-Bielschowsky disease.

Authors:  Yuko Yamada; Katsushi Doi; Shinichi Sakura; Yoji Saito
Journal:  Can J Anaesth       Date:  2002-01       Impact factor: 5.063

5.  Cardiac pathology in neuronal ceroid lipofuscinoses--a clinicopathologic correlation in three patients.

Authors:  I L Hofman; A C van der Wal; K P Dingemans; A E Becker
Journal:  Eur J Paediatr Neurol       Date:  2001       Impact factor: 3.140

6.  Effect of brain magnetic resonance imaging on body core temperature in sedated infants and children.

Authors:  A-M Machata; H Willschke; B Kabon; D Prayer; P Marhofer
Journal:  Br J Anaesth       Date:  2009-01-26       Impact factor: 9.166

7.  Iatrogenic hyperthermia during cardiac magnetic resonance imaging.

Authors:  Barry D Kussman; Robert V Mulkern; Robert S Holzman
Journal:  Anesth Analg       Date:  2004-10       Impact factor: 5.108

Review 8.  Current state of clinical and morphological features in human NCL.

Authors:  Hans H Goebel; Krystyna E Wisniewski
Journal:  Brain Pathol       Date:  2004-01       Impact factor: 6.508

9.  Convulsions on anaesthetic induction with sevoflurane in young children.

Authors:  J Akeson; I Didriksson
Journal:  Acta Anaesthesiol Scand       Date:  2004-04       Impact factor: 2.105

View more
  8 in total

1.  Risks of propofol sedation/anesthesia for imaging studies in pediatric research: eight years of experience in a clinical research center.

Authors:  Ruwan Kiringoda; Audrey E Thurm; Matthew E Hirschtritt; Deloris Koziol; Robert Wesley; Susan E Swedo; Naomi P O'Grady; Zenaide M N Quezado
Journal:  Arch Pediatr Adolesc Med       Date:  2010-06

2.  Disruption of adaptive energy metabolism and elevated ribosomal p-S6K1 levels contribute to INCL pathogenesis: partial rescue by resveratrol.

Authors:  Hui Wei; Zhongjian Zhang; Arjun Saha; Shiyong Peng; Goutam Chandra; Zenaide Quezado; Anil B Mukherjee
Journal:  Hum Mol Genet       Date:  2010-12-28       Impact factor: 6.150

3.  MRI Brain Volume Measurements in Infantile Neuronal Ceroid Lipofuscinosis.

Authors:  E H Baker; S W Levin; Z Zhang; A B Mukherjee
Journal:  AJNR Am J Neuroradiol       Date:  2016-10-20       Impact factor: 3.825

4.  Oral cysteamine bitartrate and N-acetylcysteine for patients with infantile neuronal ceroid lipofuscinosis: a pilot study.

Authors:  Sondra W Levin; Eva H Baker; Wadih M Zein; Zhongjian Zhang; Zenaide M N Quezado; Ning Miao; Andrea Gropman; Kurt J Griffin; Simona Bianconi; Goutam Chandra; Omar I Khan; Rafael C Caruso; Aiyi Liu; Anil B Mukherjee
Journal:  Lancet Neurol       Date:  2014-07-02       Impact factor: 44.182

5.  Perioperative care of a patient with neuronal ceroid lipofuscinoses.

Authors:  Hiromi Kako; David P Martin; Joseph D Tobias
Journal:  Saudi J Anaesth       Date:  2013-07

6.  Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients.

Authors:  Sara E Mole; Angela Schulz; Eben Badoe; Samuel F Berkovic; Emily C de Los Reyes; Simon Dulz; Paul Gissen; Norberto Guelbert; Charles M Lourenco; Heather L Mason; Jonathan W Mink; Noreen Murphy; Miriam Nickel; Joffre E Olaya; Maurizio Scarpa; Ingrid E Scheffer; Alessandro Simonati; Nicola Specchio; Ina Von Löbbecke; Raymond Y Wang; Ruth E Williams
Journal:  Orphanet J Rare Dis       Date:  2021-04-21       Impact factor: 4.123

7.  In a model of Batten disease, palmitoyl protein thioesterase-1 deficiency is associated with brown adipose tissue and thermoregulation abnormalities.

Authors:  Alfia Khaibullina; Nicholas Kenyon; Virginia Guptill; Martha M Quezado; Li Wang; Deloris Koziol; Robert Wesley; Pablo R Moya; Zhongjian Zhang; Arjun Saha; Anil B Mukherjee; Zenaide M N Quezado
Journal:  PLoS One       Date:  2012-11-06       Impact factor: 3.240

8.  Comprehensive functional characterization of murine infantile Batten disease including Parkinson-like behavior and dopaminergic markers.

Authors:  Joshua T Dearborn; Steven K Harmon; Stephen C Fowler; Karen L O'Malley; George T Taylor; Mark S Sands; David F Wozniak
Journal:  Sci Rep       Date:  2015-08-04       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.